This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Dainippon Sumitomo Pharma Co., Ltd. Completes Acquisition of Sepracor Inc. 2009-10-20 16:15 ET - News Release  Company Website:
http://www.sepracor.com OSAKA, Japan & MARLBOROUGH, Mass. -- (Business Wire)
Dainippon Sumitomo Pharma Co., Ltd. (“DSP”) and Sepracor Inc. (“Sepracor”)
(NASDAQ: SEPR) today announce the successful completion of DSP’s
acquisition of Sepracor for US$23.00 per share in cash. DSP completed
the acquisition through a cash tender offer and by exercising an option
to acquire additional shares directly from Sepracor followed by a
short-form merger of an indirect wholly-owned subsidiary of DSP with and
into Sepracor on October 20, 2009. Sepracor is now an indirect
wholly-owned subsidiary of DSP.
As a result of the merger, each outstanding share of Sepracor common
stock not validly tendered and accepted for payment in the tender offer
(other than shares held in the treasury of Sepracor and any shares owned
by Sepracor, DSP or any of their subsidiaries) was, subject to the
exercise of appraisal rights under Delaware law, converted into the
right to receive the same $23.00 in cash per share, without interest and
subject to applicable withholding of taxes, that was paid in the tender
offer. Computershare Trust Company, N.A., as the paying agent for the
merger, will mail to the remaining former stockholders of Sepracor
materials necessary to exchange their former Sepracor shares for such
payment. As a result of the merger, trading of Sepracor common stock on
the NASDAQ Global Select Market will cease and Sepracor will no longer
have reporting obligations under the Securities Exchange Act of 1934.
The remainder is available to Stockwatch subscribers. If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |